These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 28523)
21. Mechanism of inhibition of dihydrofolate reductases from bacterial and vertebrate sources by various classes of folate analogues. Stone SR; Morrison JF Biochim Biophys Acta; 1986 Feb; 869(3):275-85. PubMed ID: 3511964 [TBL] [Abstract][Full Text] [Related]
22. Dihydrofolate reductase from Escherichia coli: the kinetic mechanism with NADPH and reduced acetylpyridine adenine dinucleotide phosphate as substrates. Stone SR; Morrison JF Biochemistry; 1988 Jul; 27(15):5493-9. PubMed ID: 3052577 [TBL] [Abstract][Full Text] [Related]
23. Role of ionic interactions in ligand binding and catalysis of R67 dihydrofolate reductase. Hicks SN; Smiley RD; Hamilton JB; Howell EE Biochemistry; 2003 Sep; 42(36):10569-78. PubMed ID: 12962480 [TBL] [Abstract][Full Text] [Related]
24. Thermodynamic characterization of the interactions of methotrexate with dihydrofolate reductase by quantitative affinity chromatography. Waltham MC; Holland JW; Nixon PF; Winzor DJ Biochem Pharmacol; 1988 Feb; 37(3):541-5. PubMed ID: 3122765 [TBL] [Abstract][Full Text] [Related]
25. Thermal denaturation of bacterial and bovine dihydrofolate reductases and their complexes with NADPH, trimethoprim and methotrexate. Sasso S; Protasevich I; Gilli R; Makarov A; Briand C J Biomol Struct Dyn; 1995 Apr; 12(5):1023-32. PubMed ID: 7626237 [TBL] [Abstract][Full Text] [Related]
26. Interaction of methotrexate polyglutamates and dihydrofolate during leucovorin rescue in a human breast cancer cell line (MCF-7). Allegra CJ; Boarman D Cancer Res; 1990 Jun; 50(12):3574-8. PubMed ID: 1692762 [TBL] [Abstract][Full Text] [Related]
27. Unusual binding stoichiometries and cooperativity are observed during binary and ternary complex formation in the single active pore of R67 dihydrofolate reductase, a D2 symmetric protein. Bradrick TD; Beechem JM; Howell EE Biochemistry; 1996 Sep; 35(35):11414-24. PubMed ID: 8784197 [TBL] [Abstract][Full Text] [Related]
28. The importance of loop region residues 40-46 in human dihydrofolate reductase as revealed by site-directed mutagenesis. Tan XH; Huang SM; Ratnam M; Thompson PD; Freisheim JH J Biol Chem; 1990 May; 265(14):8027-32. PubMed ID: 2186034 [TBL] [Abstract][Full Text] [Related]
29. Characterization of tightly bound substrates in pure preparations of dihydrofolate reductase: implications for studies on enzymes. Williams EA; Morrison JF Biochim Biophys Acta; 1991 May; 1078(1):47-55. PubMed ID: 2049383 [TBL] [Abstract][Full Text] [Related]
30. Ultraviolet difference-spectroscopic studies of substrate and inhibitor binding to Lactobacillus casei dihydrofolate reductase. Hood K; Roberts GC Biochem J; 1978 May; 171(2):357-66. PubMed ID: 26334 [TBL] [Abstract][Full Text] [Related]
31. Methotrexate binding to dihydrofolate reductase from a methotrexate-resistant strain of Escherichia coli. Williams MN; Poe M; Greenfield NJ; Hirshfield JM; Hoogsteen K J Biol Chem; 1973 Sep; 248(18):6375-9. PubMed ID: 4147159 [No Abstract] [Full Text] [Related]
32. Critical role of phenylalanine 34 of human dihydrofolate reductase in substrate and inhibitor binding and in catalysis. Nakano T; Spencer HT; Appleman JR; Blakley RL Biochemistry; 1994 Aug; 33(33):9945-52. PubMed ID: 8061003 [TBL] [Abstract][Full Text] [Related]
33. Dihydrofolate reductase from a methotrexate-resistant Escherichia coli. Poe M; Greenfield NJ; Williams MN J Biol Chem; 1974 May; 249(9):2710-6. PubMed ID: 4151306 [No Abstract] [Full Text] [Related]
34. Conformational changes in the active site loops of dihydrofolate reductase during the catalytic cycle. Venkitakrishnan RP; Zaborowski E; McElheny D; Benkovic SJ; Dyson HJ; Wright PE Biochemistry; 2004 Dec; 43(51):16046-55. PubMed ID: 15609999 [TBL] [Abstract][Full Text] [Related]
35. Rescue effect of exogenous reduced folates on methotrexate polyglutamylation and dihydrofolate reductase activity in L1210 cells. BaliĆska M Acta Biochim Pol; 1988; 35(3):199-205. PubMed ID: 2469275 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of dihydrofolate reductase from bacterial and vertebrate sources by folate, aminopterin, methotrexate and their 5-deaza analogues. Stone SR; Montgomery JA; Morrison JF Biochem Pharmacol; 1984 Jan; 33(2):175-9. PubMed ID: 6367748 [TBL] [Abstract][Full Text] [Related]
37. Dihydrofolate reductase from soybean seedlings: a fluorescence and circular dichroism study. Reddy VA; Rao NA Arch Biochem Biophys; 1977 Sep; 183(1):90-7. PubMed ID: 20852 [No Abstract] [Full Text] [Related]
38. Nuclear magnetic resonance study of interaction of ligands with streptococcus faecium dihydrofolate reductase labeled with [gamma-13C]tryptophan. London RE; Groff JP; Cocco L; Blakley RL Biochemistry; 1982 Aug; 21(18):4450-8. PubMed ID: 7126550 [No Abstract] [Full Text] [Related]
39. NMR studies of the interaction of a type II dihydrofolate reductase with pyridine nucleotides reveal unexpected phosphatase and reductase activity. Pitcher WH; DeRose EF; Mueller GA; Howell EE; London RE Biochemistry; 2003 Sep; 42(38):11150-60. PubMed ID: 14503865 [TBL] [Abstract][Full Text] [Related]
40. Crystal structures of Escherichia coli dihydrofolate reductase: the NADP+ holoenzyme and the folate.NADP+ ternary complex. Substrate binding and a model for the transition state. Bystroff C; Oatley SJ; Kraut J Biochemistry; 1990 Apr; 29(13):3263-77. PubMed ID: 2185835 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]